| Neptune Technologies & Bioressources Inc. Enters Into Strategic Sourcing Agreement with Kinerase(R) Skincare Brand |
| Monday, October 02 2006 | |||
Neptune Technologies & Bioressources Inc. Enters Into Strategic Sourcing Agreement with Kinerase(R) Skincare BrandLAVAL, QC, Oct. 2 /CNW/ - Neptune Technologies & Bioressources Inc., (TSX.V: NTB), "Neptune" is pleased to announce it has entered into the cosmeceutical market via a strategic sourcing agreement with Kinerase(R), one of the top-selling skin care brands in dermatologist offices. The Kinerase brand included Neptune Krill Oil (NKO(TM)) in its new Kinerase Multi-Vitamins, Minerals and Nutrients. Kinerase is a non-irritating skin care regimen scientifically shown to improve the appearance of skin aging, sun damage, blotchiness and roughness. Kinerase Multi-Vitamins, Mineral and Nutrients are the latest addition to the collection and represent the brand's entrance to the supplement market. Kinerase Multi-Vitamins, Minerals and Nutrients' formula is a proprietary blend of essential vitamins and minerals combined with ingredients specifically selected for the numerous benefits that are important to women's health and skin beauty. One daily regimen contains exclusive ingredients not found in other supplements. The product was launched at the end of August and is now available to consumers through Sephora, Nordstrom and at select dermatologist and plastic surgeons. Valeant has a strong marketing campaign underway for the Kinerase product line including the use of celebrity endorsement. "Neptune is pleased that NKO(TM) has been selected for inclusion in the Kinerase(R) product line," stated Dr. Tina Sampalis, M.D., Ph.D., Vice President of R&D; and Business Development at Neptune. "Through this new partnership, Neptune has opened the door to the cosmeceutical market and expects NKO(TM) to be included in topical solutions in the future." About Neptune Technologies & Bioressources Inc. https://www.neptunebiotech.com Natural biomass extraction is now playing an important role in developing nutrigenomics, the next wave in nutritional research. Through strategic alliances and partnerships, as well as through clinical studies, the Company continues to demonstrate the immense beneficial effects of these products. The Company develops and markets new formulas and new products for specific applications in high growth markets such as the nutraceutical, cosmeceutical, biopharmaceutical and nutrigenomics markets. Neptune Technologies and Acasti Pharma Contact:
Neptune Technologies & Bioressources Inc. Acasti Pharma Inc. Toni Rinow, Ph.D., MBA Corporate Development & Investor Relations (450) 687-2262 This e-mail address is being protected from spambots, you need JavaScript enabled to view it
|